-
Meet the FDA’s Doppelganger Across the Pond: The European Medicines Agency
The European Medicines Agency is the FDA’s alter ego, but there are special regulations challenges for pharmaceutical PR executives.
Read More -
Why has pharmaceutical PR been slow to embrace social media marketing?
Pharma PR teams have moved slowly with social media promotions, despite the importance of speed. Here’s how to succeed and still stay in line with FDA...
Read More -
How the FDA is Keeping Up with the Kardashians
The FDA was none to happy with the stunt Kim Kardashian pulled with Diclegis. Here's why.
Read More -
Risk v. Benefits in Pharma Communications: Finding the Right Balance
Multimedia content is essential in pharmaceutical communications, but PR pros still need to properly balance risks and benefits in promotions.
Read More -
The FDA Speaks on Advertising via Limited Character Platforms: Guidance on the Guidance for Pharmaceutical Communications
Recent FDA Guidance on advertising via character-limited platforms offers risk-benefit compliance recommendations for pharmaceutical PR teams.
Read More -
FDA Guidance on Drug Advertising: Compliance Questions for Pharmaceutical Communications Professionals
Recent FDA Guidance on fulfilling regulatory requirements clarifies the agency’s approach on promotional content, raising compliance questions for pharma PR.
Read More -
Pharmaceutical Communications: Why Speed Matters
Pharmaceutical communications professionals are on a race against the clock and their competition when FDA approvals are issued.
Read More -
Navigating the Latest Pharmaceutical Public Relations Challenges
Pharmaceutical public relations is more challenging than ever, but better communications and connections can help you reach a sophisticated audience.
Read More
